Protective effects of fermented ginseng on streptozotocin-induced pancreatic β-cell damage through inhibition of NF-κB

International Journal of Molecular Medicine

Volumn 25, Issue 1, 2010, Pages 53-58

  Yuan, Hai Dan ^a,b   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

^b YANBIAN UNIVERSITY   (China)

Author keywords

Cyclooxygenase 2; Fermented ginseng; Inducible nitric oxide synthase; Mitogen activated protein kinases; Nitric oxide; Nuclear factor B; Tumor necrosis factor

Indexed keywords

CYCLOOXYGENASE 2; GINSENG EXTRACT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRITE; STREPTOZOCIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DAMAGE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; INSULINOMA; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TUMOR CELL;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CELL DEATH; CELL LINE; CYCLOOXYGENASE 2; FERMENTATION; GENE EXPRESSION REGULATION; GINSENOSIDES; INSULIN-SECRETING CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PANAX; PHYTOTHERAPY; PLANT PREPARATIONS; RATS; RNA, MESSENGER; STREPTOZOCIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70549102064     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000312     Document Type: Article

References (29)

1. Amirshahrokhi K, Dehpour AR, Hadjati J, Sotoudeh M and Ghazi-Khansari M: Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice. Toxicol Appl Pharmacol 232: 119-124, 2008.
2. Pirot P, Cardozo AK and Eizirik DL: Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes. Arq Bras Endocrinol Metabol 52: 156-165, 2008.
3. Zhang Y, Cai J, Ruan H, Pi H and Wu J: Antihyperglycemic activity of kinsenoside, a high yielding constituent from Anoectochilus roxburghii in streptozotocin diabetic rats. J Ethnopharmacol 114: 141-145, 2007.
4. Corbett JA, Wang JL, Misko TP, Zhao W, Hickey WF and McDaniel ML: Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone. Autoimmunity 15: 145-153, 1993.
5. Kwon NS, Lee SH, Choi CS, Kho T and Lee HS: Nitric oxide generation from streptozotocin. FASEB J 8: 529-533, 1994.
6. Yang F, Troncy E, Francceur M, Vinet B, Vinay P and Czaika G: Effects of reducing reagents and temperature on conversion of nitrite and nitrate to nitric oxide and detection of NO by chemiluminescence. Clin Chem 43: 657-662, 1997.
7. Moshage H: Nitric oxide determination: much ado about NO-thing? Clin Chem 43: 553-556, 1997.
8. Darville MI and Eizirik DL: Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41: 1101-1108, 1998.
9. Rabinovitch A and Suarez-Pinzon WL: Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 55: 1139-1149, 1998.
10. Altorki NK, Subbaramaiah K and Dannenberg AJ: Cyclooxygenase-2: a target for the prevention and treatment of cancers of the upper digestive tract. Prog Exp Tumor Res 37: 107-123, 2003.
11. Mokhtari D, Myers JW and Welsh N: MAPK kinase kinase-1 is essential for cytokine-induced c-Jun NH2-terminal kinase and nuclear factor-kappaB activation in human pancreatic islet cells. Diabetes 57: 1896-1904, 2008.
12. Kim JH, Na HK, Pak YK, Lee YS, Lee SJ, Moon A and Surh YJ: Roles of ERK and p38 mitogen-activated protein kinases in phorbol ester-induced NF-kappaB activation and COX-2 expression in human breast epithelial cells. Chem Biol Interact 171: 133-141, 2007.
13. Pan MH, Lai CS, Wang YJ and Ho CT: Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. Biochem Pharmacol 72: 1293-1303, 2006.
14. Wu Z, Luo JZ and Luo L: American ginseng modulates pancreatic beta cell activities. Chin Med 25: 2-11, 2007.
15. Kiefer D and Pantuso T: Panax ginseng. Am Fam Physician 68: 1539-1542, 2003.
16. Yin J, Zhang H and Ye J: Traditional Chinese medicine in treatment of metabolic syndrome. Endocr Metab Immune Disord Drug Targets 8: 99-111, 2008.
17. Kim DY, Park JS, Yuan HD and Chung SH: Fermented ginseng attenuates hepatic lipid accumulation and hyperglycemia through AMPK activation. Food Sci Biotechnol (In press).
18. Akli S, Chelly J, Lacorte JM, Poenaru L and Kahn A: Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. Genomics 11: 124-134, 1991.
19. Romzova M, Hohenadel D, Kolostova K, Pinterova D, Fojtikova M, Ruzickova S, Dostal C, Bosak V, Rychlik I and Cerna M: NFkappaB and its inhibitor IkappaB in relation to type 2 diabetes and its microvascular and atherosclerotic complications. Hum Immunol 67: 706-713, 2006.
20. DiDonato JA, Mercurio F and Karin M: Phosphorylation of Ikappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol Cell Biol 15: 1302-1311, 1995.
21. Seo JY, Lee JH, Kim NW, Her E, Chang SH, Ko NY, Yoo HY, Kim JW, Seo DW, Han JW, Kim YM and Choi WS: Effect of fermented ginseng extract, BST204, on the expression of cyclooxygenase-2 in murine machropharges. Int Immunopharmacol 5: 929-936, 2005.
22. Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH and Yue KK: Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol 550: 173-179, 2006.
23. Zamora R, Vodovotz Y and Billiar TR: Inducible nitric oxide synthase and inflammatory diseases. Mol Med 6: 347-373, 2000.
24. Kim EK, Kwon KB, Song MY, Seo SW, Park SJ, Ka SO, Na L, Kim KA, Ryu DG, So HS, Park R, Park JW and Park BH: Genistein protects pancreatic beta cells against cytokine-mediated toxicity. Mol Cell Endocrinol 278: 18-28, 2007.
25. Matsuda T, Ferreri K, Todorov I, Kuroda Y, Smith CV, Kandeel F and Mullen Y: Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways. Endocrinology 146: 175-185, 2005.
26. Kim EK, Kwon KB, Song MY, Han MJ, Lee JH, Lee YR, Lee JH, Ryu DG, Park BH and Park JW: Flavonoids protect against cytokine-induced pancreatic beta-cell damage through suppression of nuclear factor kappaB activation. Pancreas 35: E1-E9, 2007.
27. Kim S, Millet I, Kim HS, Kim JY, Han MS, Lee MK, Kim KW, Sherwin RS, Karin M and Lee MS: NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci USA 104: 1913-1918, 2007.
28. Kwon G, Corbett JA, Hauser S, Hill JR, Turk J and McDaniel ML: Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes 47: 583-591, 1998.
29. Rodriguez MS, Thompson J, Hay RT and Dargemont C: Nuclear retention of IkappaBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation. J Biol Chem 274: 9108-9115, 1999.